Does large scale DNA sequencing of patient and tumor DNA yet provide clinically actionable information?

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Discover medicine

• Publication date

  2010-08-01

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 20807475
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Aggressive lymphomas.

  2010cited by this paper
• PARP inhibition: PARP1 and beyond

  2010cited by this paper
• U87MG Decoded: The Genomic Sequence of a Cytogenetically Aberrant Human Cancer Cell Line

  2010cited by this paper
• The landscape of somatic copy-number alteration across human cancers

  2010cited by this paper
• Signatures of mutation and selection in the cancer genome

  2010cited by this paper
• Personalized medicine in oncology: the future is now

  2010cited by this paper
• Genomewide association studies and assessment of the risk of disease.

  2010cited by this paper
• Development of Personalized Tumor Biomarkers Using Massively Parallel Sequencing

  2010cited by this paper
• Gene and drug matrix for personalized cancer therapy

  2010cited by this paper
• The molecular pathology of cancer

  2010cited by this paper
• Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1.

  2010cited by this paper
• Metabolism, gliomas, and IDH1.

  2010cited by this paper
• Genome-wide association studies in cancer--current and future directions.

  2010cited by this paper
• Integrative analysis of the melanoma transcriptome.

  2010cited by this paper
• A comprehensive catalogue of somatic mutations from a human cancer genome

  2010cited by this paper
• De novo mutations of SETBP1 cause Schinzel-Giedion syndrome

  2010cited by this paper
• Target-enrichment strategies for next-generation sequencing

  2010cited by this paper
• Performance of common genetic variants in breast-cancer risk models.

  2010cited by this paper
• Third-generation sequencing fireworks at Marco Island

  2010cited by this paper
• Genetic heterogeneity in human disease.

  2010cited by this paper
• Genome Remodeling in a Basal-like Breast Cancer Metastasis and Xenograft

  2010cited by this paper
• The mutation spectrum revealed by paired genome sequences from a lung cancer patient

  2010cited by this paper
• A small cell lung cancer genome reports complex tobacco exposure signatures

  2009cited by this paper
• Integration of Molecular Profiling into the Lung Cancer Clinic

  2009cited by this paper
• Cancer research. Melanoma drug vindicates targeted approach.

  2009cited by this paper
• Profiling Critical Cancer Gene Mutations in Clinical Tumor Samples

  2009cited by this paper
• Exome sequencing identifies the cause of a Mendelian disorder

  2009cited by this paper
• Synthetic lethal targeting of PTEN mutant cells with PARP inhibitors

  2009cited by this paper
• Inhibition of ALK Signaling for Cancer Therapy

  2009cited by this paper
• Finding the missing heritability of complex diseases

  2009cited by this paper
• Multi-Determinants Analysis of Molecular Alterations for Predicting Clinical Benefit to EGFR-Targeted Monoclonal Antibodies in Colorectal Cancer

  2009cited by this paper
• Transcriptome Sequencing to Detect Gene Fusions in Cancer

  2009cited by this paper
• Recurring mutations found by sequencing an acute myeloid leukemia genome.

  2009cited by this paper
• Targeted Capture and Massively Parallel Sequencing of Twelve Human Exomes

  2009cited by this paper
• Polygenes, risk prediction, and targeted prevention of breast cancer.

  2008cited by this paper
• Identification of somatically acquired rearrangements in cancer using genome-wide massively parallel paired-end sequencing

  2008cited by this paper
• DNA sequencing of a cytogenetically normal acute myeloid leukemia genome

  2008cited by this paper
• Next-generation DNA sequencing

  2008cited by this paper

• Extraction of Genetic Mutations Associated with Cancer from Public Literature

  2013cites this paper
• RET融合基因在非小细胞肺癌诊治中的意义

  2013cites this paper
• A transforming KIF5B and RET gene fusion in lung adenocarcinoma revealed from whole-genome and transcriptome sequencing.

  2012influential citation
• Genomic and genetic characterization of cholangiocarcinoma identifies therapeutic targets for tyrosine kinase inhibitors.

  2012cites this paper
• sequencing adenocarcinoma revealed from whole-genome and transcriptome gene fusion in lung RET and KIF 5 B A transforming Material Supplemental

  2012influential citation
• Extraction of Genetic Mutations Associated with Cancer from Public

  2012cites this paper